Glatiramer acetate

🧮 Dose calculator

Multiple sclerosis (relapsing) · Regimen source: FDA Copaxone · 2.1

• • 20 mg and 40 mg are not interchangeable. Never IV. Warm to room temperature first. FDA Copaxone · 2.1FDA Copaxone · 2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Copaxone · 8.1

  “Risk Summary Available data from pharmacovigilance and published observational studies over decades of use with glatiramer acetate during pregnancy have not identified a drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes (see Data) .”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Copaxone · 8.2

  “Risk Summary There are no data on the presence of glatiramer acetate in human milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Copaxone · 8.4

  “The safety and effectiveness of COPAXONE have not been established in patients under 18 years of age.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Copaxone · 8.5

  “COPAXONE has not been studied in elderly patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.